Related Experiment Video
Updated: Aug 12, 2026
10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
[Immunotherapy of pulmonary tuberculosis]
Problemy Tuberkuleza
|March 6, 1999
Summary
This study compared immune correctors for destructive tuberculosis. Thymogen combined with interferon showed the best early therapeutic benefits, particularly after lung fibrosis healed.
Area of Science:
- Immunology
- Pulmonology
- Pharmacology
Background:
- Destructive tuberculosis presents significant treatment challenges.
- Immunomodulatory agents are explored to enhance therapeutic outcomes.
- Understanding the role of immune correctors in tuberculosis management is crucial.
Purpose of the Study:
- To comparatively analyze the efficacy of different immune correctors in treating destructive tuberculosis.
- To identify the most effective immunocorrector regimen for patients with destructive tuberculosis.
- To evaluate the impact of immune corrector therapy on lung tissue healing and residual changes.
Main Methods:
- A comparative analysis involving 553 patients with destructive tuberculosis.
- Treatment groups included thymalin, thymogen, human leukocytic interferon, and a combination of thymogen and interferon.
- Evaluation of treatment benefits, timing of efficacy, and impact on lung fibrosis and residual changes.
Main Results:
- Early therapeutic benefits were observed with immunocorrector treatment as part of complex therapy.
- The combination of thymogen and interferon yielded the best therapeutic results.
- The efficacy of thymogen and interferon was more pronounced following the healing of lung fibrous deformity, but this was followed by residual changes.
Conclusions:
- Immune correctors can provide early benefits in the complex treatment of destructive tuberculosis.
- The combination of thymogen and interferon appears to be the most effective immunomodulatory approach.
- Further research is needed to mitigate residual changes after successful treatment of lung fibrosis.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...